The latest prostate cancer news
Research supports early use of LuPSMA in prostate cancer
Peter Mac researchers have shown LuPSMA therapy can be safely used as a first-line treatment…
Browsing: Prostate Cancer
Precision medicine improves survival outcomes for patients with metastatic castration-resistant prostate cancer with BRCA gene alterations
Led by Joaquin Mateo, Principal Investigator of the Vall d’Hebron Institute of Oncology’s (VHIO) Prostate Cancer…
Treatment strategy for certain advanced prostate cancers shows promise in preclinical models
Epigenetic changes can cause prostate cancer to resist treatment by switching genes on or off.…
FDA approves enzalutamide for non-metastatic castration-sensitive prostate cancer with biochemical recurrence
On November 16, 2023, the US Food and Drug Administration approved enzalutamide (Xtandi, Astellas Pharma…
New insights into DNA repair pathway implicated in breast,ovarian and prostate cancers revealed
Our DNA is not indestructible. Throughout the course of our lives, DNA can break in…
Gene that drives prostate cancer growth identified
New research from scientists at VCU Massey Comprehensive Cancer Center and the VCU Institute of…
Research uncovers genetic clues to high rates of prostate cancer in men with African ancestry – improving risk prediction
More equitable testing for prostate cancer risk is on the horizon, as researchers report findings…
Radiopharmaceutical shows early promise in prostate cancer trial
Researchers at Weill Cornell Medicine, USA, have led a phase 1 trial of a new…
Black men more likely to have prostate cancer than white men at same PSA level
Black men in the United States are more likely to develop prostate cancer than white…
ESMO 2023: Lutetium (177Lu) vipivotide tetraxetan shows clinically meaningful and highly statistically significant rPFS benefit in patients with PSMA-positive mCRPC in the pre-taxane setting
The data from the Phase III PSMAfore trial was presented at the 2023 European Society…